Title
Empirical evidence for psychopharmacologic treatment in early-onset psychosis and schizophrenia
UMMS Affiliation
Department of Psychiatry
Publication Date
2012-10
Document Type
Article
Subjects
Antipsychotic Agents; Psychotic Disorders; Schizophrenia
Disciplines
Medical Pharmacology | Mental and Social Health | Psychiatry | Psychiatry and Psychology
Abstract
Psychotic symptoms presenting in youth can be clinically complex and require that a child and adolescent psychiatrist use significant skill in making a diagnosis and initiating treatment. There are a number of illnesses to rule out before making a diagnosis of early-onset schizophrenia in particular. Psychosis in youth has significant associated morbidity and places high demands not only on families but also on the medical and educational systems. More effective pharmacologic and nonpharmacologic treatments for psychosis are needed. Nonpharmacologic therapies targeting relatively treatment-resistant domains of dysfunction such as neurocognition are also necessary as adjunctive treatments to our extant pharmacologic agents.
DOI of Published Version
10.1016/j.chc.2012.07.011
Source
Child Adolesc Psychiatr Clin N Am. 2012 Oct;21(4):885-909. doi: 10.1016/j.chc.2012.07.011. Link to article on publisher's site
Journal/Book/Conference Title
Child and adolescent psychiatric clinics of North America
Related Resources
PubMed ID
23040906
Repository Citation
Maloney AE, Yakutis LJ, Frazier JA. (2012). Empirical evidence for psychopharmacologic treatment in early-onset psychosis and schizophrenia. Psychiatry Publications and Presentations. https://doi.org/10.1016/j.chc.2012.07.011. Retrieved from https://escholarship.umassmed.edu/psych_pp/564